Publications

Development and Application of 3D Cardiac Tissues Derived from Human Pluripotent Stem Cells

Masatoshi Ohno, Hidenori Tani, Shugo Tohyama *

Drug Metabolism and Pharmacokinetics 60 101049-101049, 4 January 2025

Metabolic changes of human induced pluripotent stem cell-derived cardiomyocytes and teratomas after transplantation 

Yusuke Soma, Shugo Tohyama*, Akiko Kubo, Tomoteru Yamasaki, Noriko Kabasawa, Kotaro Haga, Hidenori Tani, Yuika Morita-Umei, Tomohiko C. Umei, Otoya Sekine, Masashi Nakamura, Taijun Moriwaki, Sho Tanosaki, Shota Someya, Yujiro Kawai, Masatoshi Ohno, Yoshikazu Kishino, Hideaki Kanazawa, Jun Fujita, Ming-Rong Zhang, Makoto Suematsu, Keiichi Fukuda, Masaki Ieda

iScience 27(11) 111234-111234, November 2024

Maturation of Human iPSC-Derived Cardiac Microfiber with Electrical Stimulation Device 

Akari Masuda, Yuta Kurashina, Hidenori Tani, Yusuke Soma, Jumpei Muramatsu, Shun Itai, Shugo Tohyama*, Hiroaki Onoe*

Advanced healthcare materials 13(27) e2303477, 29 May 2024

Regeneration of Nonhuman Primate Hearts With Human Induced Pluripotent Stem Cell-Derived Cardiac Spheroids. 

Hideki Kobayashi, Shugo Tohyama*, Hajime Ichimura, Noburo Ohashi, Shuji Chino, Yusuke Soma, Hidenori Tani, Yuki Tanaka, Xiao Yang, Naoko Shiba, Shin Kadota, Kotaro Haga, Taijun Moriwaki, Yuika Morita-Umei, Tomohiko C Umei, Otoya Sekine, Yoshikazu Kishino, Hideaki Kanazawa, Hiroyuki Kawagishi, Mitsuhiko Yamada, Kazumasa Narita, Takafumi Naito, Tatsuichiro Seto, Koichiro Kuwahara, Yuji Shiba*, Keiichi Fukuda

Circulation 150(8) 611-621, 26 April 2024

PRESS RELEASE

H1FOO-DD promotes efficiency and uniformity in reprogramming to naive pluripotency. 

Akira Kunitomi, Ryoko Hirohata, Mitsujiro Osawa, Kaho Washizu, Vanessa Arreola, Norikazu Saiki, Tomoaki M Kato, Masaki Nomura, Haruko Kunitomi, Tokiko Ohkame, Yusuke Ohkame, Jitsutaro Kawaguchi, Hiroto Hara, Kohji Kusano, Takuya Yamamoto, Yasuhiro Takashima, Shugo Tohyama, Shinsuke Yuasa, Keiichi Fukuda, Naoko Takasu, Shinya Yamanaka

Stem cell reports 19(5) 710-728, 23 April 2024

Pluripotent stem cell-based cardiac regenerative therapy for heart failure. 

Yusuke Soma, Hidenori Tani, Yuika Morita-Umei, Yoshikazu Kishino, Keiichi Fukuda, Shugo Tohyama*

Journal of molecular and cellular cardiology 187 90-100, February 2024

Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in actin binding domain 1. 

Naoko Shiba, Xiao Yang, Mitsuto Sato, Shin Kadota, Yota Suzuki, Masahiro Agata, Kohei Nagamine, Masaki Izumi, Yusuke Honda, Tomoya Koganehira, Hideki Kobayashi, Hajime Ichimura, Shinichiro Chuma, Junichi Nakai, Shugo Tohyama, Keiichi Fukuda, Daigo Miyazaki, Akinori Nakamura, Yuji Shiba

Molecular therapy. Nucleic acids 34 102060-102060, 12 December 2023

Scalable production of homogeneous cardiac organoids derived from human pluripotent stem cells 

Taijun Moriwaki, Hidenori Tani, Kotaro Haga, Yuika Morita-Umei, Yusuke Soma, Tomohiko C. Umei, Otoya Sekine, Kaworu Takatsuna, Yoshikazu Kishino, Hideaki Kanazawa, Jun Fujita, Keiichi Fukuda, Shugo Tohyama*, Masaki Ieda

Cell Reports Methods 3(12) 100666-100666, December 2023

Hydrogel-Sheathed HiPSC-Derived Heart Microtissue Enables Anchor-Free Contractile Force Measurement. 

Yuta Kurashina, Keisuke Fukada, Shun Itai, Shuichi Akizuki, Ryo Sato, Akari Masuda, Hidenori Tani, Jun Fujita, Keiichi Fukuda, Shugo Tohyama*, Hiroaki Onoe*

Advanced Science e2301831, 17 October 2023

Mature human induced pluripotent stem cell-derived cardiomyocytes promote angiogenesis through alpha-B crystallin. 

Yuki Tanaka, Shin Kadota, Jian Zhao, Hideki Kobayashi, Satomi Okano, Masaki Izumi, Yusuke Honda, Hajime Ichimura, Naoko Shiba, Takeshi Uemura, Yuko Wada, Shinichiro Chuma, Tsutomu Nakada, Shugo Tohyama, Keiichi Fukuda, Mitsuhiko Yamada, Tatsuichiro Seto, Koichiro Kuwahara, Yuji Shiba

Stem cell research & therapy 14(1) 240-240, 07 September 2023

Seamless and non-destructive monitoring of extracellular microRNAs during cardiac differentiation from human pluripotent stem cells. 

Otoya Sekine, Sayaka Kanaami, Kanako Masumoto, Yuki Aihara, Yuika Morita-Umei, Hidenori Tani, Yusuke Soma, Tomohiko C Umei, Kotaro Haga, Taijun Moriwaki, Yujiro Kawai, Masatoshi Ohno, Yoshikazu Kishino, Hideaki Kanazawa, Keiichi Fukuda, Masaki Ieda, Shugo Tohyama*

Stem Cell Reports, 31 August 2023

PRESS RELEASE

Heart-derived collagen promotes maturation of engineered heart tissue. 

Hidenori Tani, Eiji Kobayashi, Shinomi Yagi, Keisuke Tanaka, Kotaro Kameda-Haga, Shinsuke Shibata, Nobuko Moritoki, Kaworu Takatsuna, Taijun Moriwaki, Otoya Sekine, Tomohiko C Umei, Yuika Morita, Yusuke Soma, Yoshikazu Kishino, Hideaki Kanazawa, Jun Fujita, Shunji Hattori, Keiichi Fukuda, Shugo Tohyama*

Biomaterials 299 122174-122174, August 2023

PRESS RELEASE

Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review. 

Yoshikazu Kishino, Shugo Tohyama*, Yuika Morita, Yusuke Soma, Hidenori Tani, Marina Okada, Hideaki Kanazawa, Keiichi Fukuda

Journal of cardiac failure 29(4) 503-513, April 2023

An Approach That Brings Out the Potential of Regenerative Therapies in Heart Failure. 

Yoshikazu Kishino, Shugo Tohyama*

Circulation journal : official journal of the Japanese Circulation Society 87(4) 487-489, 24 March 2023

Metabolism-based cardiomyocytes production for regenerative therapy. 

Tomohiko C Umei, Shugo Tohyama*, Keiichi Fukuda

Journal of molecular and cellular cardiology 176 11-20, 01 March 2023

Intracoronary transplantation of pluripotent stem cell-derived cardiomyocytes: Inefficient procedure for cardiac regeneration. 

Hideki Kobayashi, Shugo Tohyama*, Hideaki Kanazawa, Hajime Ichimura, Shuji Chino, Yuki Tanaka, Yota Suzuki, Jian Zhao, Naoko Shiba, Shin Kadota, Kazumasa Narita, Takafumi Naito, Tatsuichiro Seto, Koichiro Kuwahara, Yuji Shiba*, Keiichi Fukuda

Journal of molecular and cellular cardiology 174 77-87, 18 October 2022

Purification of cardiomyocytes and neurons derived from human pluripotent stem cells by inhibition of de novo fatty acid synthesis. 

Sho Tanosaki, Tomohiko Akiyama, Sayaka Kanaami, Jun Fujita, Minoru S H Ko, Keiichi Fukuda, Shugo Tohyama*

STAR Protocols 3(2) 101360-101360, 17 June 2022

Protocol for enhanced proliferation of human pluripotent stem cells in tryptophan-fortified media. 

Kotaro Kameda, Shota Someya, Jun Fujita, Keiichi Fukuda, Shugo Tohyama*

STAR Protocols 3(2) 101341-101341, 17 June 2022

Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy. 

Yuika Morita, Yoshikazu Kishino, Keiichi Fukuda, Shugo Tohyama*

Cell proliferation e13248, 09 May 2022

Metabolism in Human Pluripotent Stem Cells and Cardiomyocytes for Regenerative Therapy. 

Tomohiko C Umei, Shugo Tohyama*

The Keio journal of medicine, 25 January 2022

Scaffold-Free Tubular Engineered Heart Tissue From Human Induced Pluripotent Stem Cells Using Bio-3D Printing Technology in vivo. 

Yujiro Kawai, Shugo Tohyama*, Kenichi Arai, Tadashi Tamura, Yusuke Soma, Keiichi Fukuda, Hideyuki Shimizu, Koichi Nakayama*, Eiji Kobayashi

Frontiers in cardiovascular medicine 8 806215-806215, 20 January 2022

Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery. 

Hidenori Tani, Shugo Tohyama*

Frontiers in cell and developmental biology 10 855763-855763, 2022

Clinical Application of iPSC-Derived Cardiomyocytes in Patients with Advanced Heart Failure 

Jun Fujita, Shugo Tohyama*, Hideaki Kanazawa, Yoshikazu Kishino, Marina Okada, Sho Tanosaki, Shota Someya, Keiichi Fukuda

Advanced Technologies in Cardiovascular Bioengineering, Springer 361-374, January 2022

The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells. 

Yusuke Soma, Yuika Morita, Yoshikazu Kishino, Hideaki Kanazawa, Keiichi Fukuda, Shugo Tohyama*

Frontiers in cardiovascular medicine 8 774389-774389, 08 December 2021

Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy. 

Hidenori Tani, Shugo Tohyama*, Yoshikazu Kishino, Hideaki Kanazawa, Keiichi Fukuda

Journal of molecular and cellular cardiology 164 83-91, 22 November 2021

Intramyocardial Transplantation of Human iPS Cell-Derived Cardiac Spheroids Improves Cardiac Function in Heart Failure Animals. 

Shinji Kawaguchi, Yusuke Soma, Kazuaki Nakajima, Hideaki Kanazawa, Shugo Tohyama, Ryota Tabei, Akinori Hirano, Noriko Handa, Yoshitake Yamada, Shigeo Okuda, Shuji Hishikawa, Takumi Teratani, Satoshi Kunita, Yoshikazu Kishino, Marina Okada, Sho Tanosaki, Shota Someya, Yuika Morita, Hidenori Tani, Yujiro Kawai, Masataka Yamazaki, Akira Ito, Rei Shibata, Toyoaki Murohara, Yasuhiko Tabata, Eiji Kobayashi, Hideyuki Shimizu, Keiichi Fukuda, Jun Fujita

JACC. Basic to translational science 6(3) 239-254, March 2021

Tryptophan Metabolism Regulates Proliferative Capacity of Human Pluripotent Stem Cells. 

Shota Someya, Shugo Tohyama*, Kotaro Kameda, Sho Tanosaki, Yuika Morita, Kazunori Sasaki, Moon-Il Kang, Yoshikazu Kishino, Marina Okada, Hidenori Tani, Yusuke Soma, Kazuaki Nakajima, Tomohiko Umei, Otoya Sekine, Taijun Moriwaki, Hideaki Kanazawa, Eiji Kobayashi, Jun Fujita, Keiichi Fukuda

iScience 24(2) 102090-102090, 19 February 2021

PRESS RELEASE

Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes. 

Sho Tanosaki, Shugo Tohyama*, Yoshikazu Kishino, Jun Fujita, Keiichi Fukuda

Inflammation and regeneration 41(1) 5-5, 01 February 2021

A Method for Cardiac Differentiation, Purification, and Cardiac Spheroid Production of Human Induced Pluripotent Stem Cells. 

Yuika Morita, Shugo Tohyama*, Jun Fujita, Keiichi Fukuda

Methods in molecular biology (Clifton, N.J.) 2320 11-21, 2021

Fatty Acid Synthesis Is Indispensable for Survival of Human Pluripotent Stem Cells. 

Sho Tanosaki, Shugo Tohyama*, Jun Fujita, Shota Someya, Takako Hishiki, Tomomi Matsuura, Hiroki Nakanishi, Takayo Ohto-Nakanishi, Tomohiko Akiyama, Yuika Morita, Yoshikazu Kishino, Marina Okada, Hidenori Tani, Yusuke Soma, Kazuaki Nakajima, Hideaki Kanazawa, Masahiro Sugimoto, Minoru S H Ko, Makoto Suematsu, Keiichi Fukuda

iScience 23(9) 101535-101535, 01 September 2020

PRESS RELEASE

Increased predominance of the matured ventricular subtype in embryonic stem cell-derived cardiomyocytes in vivo. 

Hajime Ichimura, Shin Kadota, Toshihide Kashihara, Mitsuhiko Yamada, Kuniaki Ito, Hideki Kobayashi, Yuki Tanaka, Naoko Shiba, Shinichiro Chuma, Shugo Tohyama, Tatsuichiro Seto, Kenji Okada, Koichiro Kuwahara, Yuji Shiba

Scientific reports 10(1) 11883-11883, 17 July 2020

Metabolic Regulation of Cardiac Differentiation and Maturation in Pluripotent Stem Cells: A Lesson from Heart Development. 

Yuika Morita, Shugo Tohyama*

JMA journal 3(3) 193-200, 15 July 2020

Organ Fabrication Using Pigs as An in Vivo Bioreactor. 

Eiji Kobayashi, Shugo Tohyama, Keiichi Fukuda

The Keio journal of medicine 69(2) 30-36, 25 June 2020

Cost-effective culture of human induced pluripotent stem cells using UV/ozone-modified culture plastics with reduction of cell-adhesive matrix coating. 

Kohei Kasai, Shugo Tohyama, Hayato Suzuki, Sho Tanosaki, Keiichi Fukuda, Jun Fujita, Shogo Miyata

Materials science & engineering. C, Materials for biological applications 111 110788-110788 , June 2020

Toward the realization of cardiac regenerative medicine using pluripotent stem cells. 

Yoshikazu Kishino, Jun Fujita, Shugo Tohyama, Marina Okada, Sho Tanosaki, Shota Someya, Keiichi Fukuda

Inflammation and regeneration 40 1-1, 2020

An effective detachment system for human induced pluripotent stem cells cultured on multilayered cultivation substrates using resonance vibrations. 

Yusuke Terao, Yuta Kurashina, Shugo Tohyama, Yuki Fukuma, Keiichi Fukuda, Jun Fujita, Kenjiro Takemura

Scientific reports 9(1) 15655-15655, 30 October 2019

Concise Review: Genetic and Epigenetic Regulation of Cardiac Differentiation from Human Pluripotent Stem Cells. 

Jun Fujita, Shugo Tohyama, Yoshikazu Kishino, Marina Okada, Yuika Morita

Stem cells (Dayton, Ohio) 37(8) 992-1002, August 2019

Selective elimination of undifferentiated human pluripotent stem cells using pluripotent state-specific immunogenic antigen Glypican-3. 

Marina Okada, Yoshitaka Tada, Tomohisa Seki, Shugo Tohyama, Jun Fujita, Toshihiro Suzuki, Manami Shimomura, Kazuya Ofuji, Yoshikazu Kishino, Kazuaki Nakajima, Sho Tanosaki, Shota Someya, Hideaki Kanazawa, Satoru Senju, Tetsuya Nakatsura, Keiichi Fukuda

Biochemical and biophysical research communications 511(3) 711-717, 09 April 2019

Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes. 

Ryota Tabei, Shinji Kawaguchi, Hideaki Kanazawa, Shugo Tohyama, Akinori Hirano, Noriko Handa, Shuji Hishikawa, Takumi Teratani, Satoshi Kunita, Junichi Fukuda, Yoshihiro Mugishima, Tsuneyoshi Suzuki, Kazuaki Nakajima, Tomohisa Seki, Yoshikazu Kishino, Marina Okada, Masataka Yamazaki, Kazuma Okamoto, Hideyuki Shimizu, Eiji Kobayashi, Yasuhiko Tabata, Jun Fujita, Keiichi Fukuda

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 38(2) 203-214, February 2019

Age-Appropriateness of Porcine Models Used for Cell Transplantation. 

Shugo Tohyama, Eiji Kobayashi

Cell transplantation 28(2) 224-228, February 2019

Tbx6 Induces Nascent Mesoderm from Pluripotent Stem Cells and Temporally Controls Cardiac versus Somite Lineage Diversification. 

Taketaro Sadahiro, Mari Isomi, Naoto Muraoka, Hidenori Kojima, Sho Haginiwa, Shota Kurotsu, Fumiya Tamura, Hidenori Tani, Shugo Tohyama, Jun Fujita, Hiroyuki Miyoshi, Yoshifumi Kawamura, Naoki Goshima, Yuka W Iwasaki, Kensaku Murano, Kuniaki Saito, Mayumi Oda, Peter Andersen, Chulan Kwon, Hideki Uosaki, Hirofumi Nishizono, Keiichi Fukuda, Masaki Ieda

Cell stem cell 23(3) 382-395, 06 September 2018

Efficient Large-Scale 2D Culture System for Human Induced Pluripotent Stem Cells and Differentiated Cardiomyocytes. 

Shugo Tohyama, Jun Fujita, Chihana Fujita, Miho Yamaguchi, Sayaka Kanaami, Rei Ohno, Kazuho Sakamoto, Masami Kodama, Junko Kurokawa, Hideaki Kanazawa, Tomohisa Seki, Yoshikazu Kishino, Marina Okada, Kazuaki Nakajima, Sho Tanosaki, Shota Someya, Akinori Hirano, Shinji Kawaguchi, Eiji Kobayashi, Keiichi Fukuda

Stem Cell Reports 9(5) 1406-1414, 14 November 2017

PRESS RELEASE

Epigenetic barrier against the propagation of fluctuating gene expression in embryonic stem cells 

Yuki Saito, Akira Kunitomi, Tomohisa Seki, Shugo Tohyama, Dai Kusumoto, Makoto Takei, Shin Kashimura, Hisayuki Hashimoto, Gakuto Yozu, Chikaaki Motoda, Masaya Shimojima, Toru Egashira, Mayumi Oda, Keiichi Fukuda, Shinsuke Yuasa

FEBS LETTERS 591(18) 2879-2889, 01 September 2017

Safe and Effective Cardiac Regenerative Therapy With Human-Induced Pluripotent Stem Cells: How Should We Prepare Pure Cardiac Myocytes? 

Shugo Tohyama*, Keiichi Fukuda

Circulation Research 120(10) 1558-1560, 12 May 2017

Emerin plays a crucial role in nuclear invagination and in the nuclear calcium transient. 

Masaya Shimojima, Shinsuke Yuasa, Chikaaki Motoda, Gakuto Yozu, Toshihiro Nagai, Shogo Ito, Mark Lachmann, Shin Kashimura, Makoto Takei, Dai Kusumoto, Akira Kunitomi, Nozomi Hayashiji, Tomohisa Seki, Shugo Tohyama, Hisayuki Hashimoto, Masaki Kodaira, Toru Egashira, Kenshi Hayashi, Chiaki Nakanishi, Kenji Sakata, Masakazu Yamagishi, Keiichi Fukuda

Scientific reports 7 44312-44312, 14 March 2017

Cryoinjury-induced acute myocardial infarction model and ameroid constrictor-induced ischemic heart disease model in adult micro-mini pigs for preclinical studies. 

Hirano A, Fujita J, Kanazawa H, Kawaguchi S, Handa N, Yamada Y, Okuda S, Hishikawa S, Teratani T, Kunita S, Tohyama S, Seki T, Tabei R, Nakajima K, Kishino Y, Okada M, Okamoto K, Shimizu H, Kobayashi E, Fukuda K

Translational Medicine Communications 2(1), 01 February 2017

Enhancing Survival of Human Hepatocytes by Neonatal Thymectomy and Partial Hepatectomy in Micro-miniature Pigs 

H. C. Hsu, S. Enosawa, T. Yamazaki, S. Tohyama, J. Fujita, K. Fukuda, E. Kobayashi

TRANSPLANTATION PROCEEDINGS 49(1) 153-158, January 2017

Manipulation of Pluripotent Stem Cell Metabolism for Clinical Application. 

Shugo Tohyama, Sho Tanosaki, Shota Someya, Jun Fujita, Keiichi Fukuda

Current stem cell reports 3(1) 28-34 , 2017

ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism. 

Zhe Tian, Keishi Miyata, Tsuyoshi Kadomatsu, Haruki Horiguchi, Hiroyuki Fukushima, Shugo Tohyama, Yoshihiro Ujihara, Takahiro Okumura, Satoshi Yamaguchi, Jiabin Zhao, Motoyoshi Endo, Jun Morinaga, Michio Sato, Taichi Sugizaki, Shunshun Zhu, Kazutoyo Terada, Hisashi Sakaguchi, Yoshihiro Komohara, Motohiro Takeya, Naoki Takeda, Kimi Araki, Ichiro Manabe, Keiichi Fukuda, Kinya Otsu, Jun Wada, Toyoaki Murohara, Satoshi Mohri, Jun K Yamashita, Motoaki Sano, Yuichi Oike

Nature communications 7 13016-13016, 28 September 2016

H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells. 

Akira Kunitomi, Shinsuke Yuasa, Fumihiro Sugiyama, Yuki Saito, Tomohisa Seki, Dai Kusumoto, Shin Kashimura, Makoto Takei, Shugo Tohyama, Hisayuki Hashimoto, Toru Egashira, Yoko Tanimoto, Saori Mizuno, Shoma Tanaka, Hironobu Okuno, Kazuki Yamazawa, Hideo Watanabe, Mayumi Oda, Ruri Kaneda, Yumi Matsuzaki, Toshihiro Nagai, Hideyuki Okano, Ken-Ichi Yagami, Mamoru Tanaka, Keiichi Fukuda

Stem cell reports 6(6) 825-833, 14 June 2016

Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells. 

Shugo Tohyama, Jun Fujita, Takako Hishiki, Tomomi Matsuura, Fumiyuki Hattori, Rei Ohno, Hideaki Kanazawa, Tomohisa Seki, Kazuaki Nakajima, Yoshikazu Kishino, Marina Okada, Akinori Hirano, Takuya Kuroda, Satoshi Yasuda, Yoji Sato, Shinsuke Yuasa, Motoaki Sano, Makoto Suematsu, Keiichi Fukuda

Cell Metabolism 23(4) 663-74, 12 April 2016

PRESS RELEASE

Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes. 

Toru Egashira, Shinsuke Yuasa, Shugo Tohyama, Yusuke Kuroda, Tomoyuki Suzuki, Tomohisa Seki, Keiichi Fukuda

Methods in molecular biology (Clifton, N.J.) 1353 343-53, 2016

Future Treatment of Heart Failure Using Human iPSC-Derived Cardiomyocytes 

Shugo Tohyama, Keiichi Fukuda

Etiology and Morphogenesis of Congenital Heart Disease 25-31, 2016

Analysis of cardiomyocyte movement in the developing murine heart. 

Hisayuki Hashimoto, Shinsuke Yuasa, Hidenori Tabata, Shugo Tohyama, Tomohisa Seki, Toru Egashira, Nozomi Hayashiji, Fumiyuki Hattori, Dai Kusumoto, Akira Kunitomi, Makoto Takei, Shin Kashimura, Gakuto Yozu, Masaya Shimojima, Chikaaki Motoda, Naoto Muraoka, Kazunori Nakajima, Asako Sakaue-Sawano, Atsushi Miyawaki, Keiichi Fukuda

Biochemical and biophysical research communications 464(4) 1000-1007, 04 September 2015

G-CSF supports long-term muscle regeneration in mouse models of muscular dystrophy. 

Nozomi Hayashiji, Shinsuke Yuasa, Yuko Miyagoe-Suzuki, Mie Hara, Naoki Ito, Hisayuki Hashimoto, Dai Kusumoto, Tomohisa Seki, Shugo Tohyama, Masaki Kodaira, Akira Kunitomi, Shin Kashimura, Makoto Takei, Yuki Saito, Shinichiro Okata, Toru Egashira, Jin Endo, Toshikuni Sasaoka, Shin'ichi Takeda, Keiichi Fukuda

Nature communications 6 6745-6745, 13 April 2015

Impaired respiratory function in MELAS-induced pluripotent stem cells with high heteroplasmy levels. 

Masaki Kodaira, Hideyuki Hatakeyama, Shinsuke Yuasa, Tomohisa Seki, Toru Egashira, Shugo Tohyama, Yusuke Kuroda, Atsushi Tanaka, Shinichiro Okata, Hisayuki Hashimoto, Dai Kusumoto, Akira Kunitomi, Makoto Takei, Shin Kashimura, Tomoyuki Suzuki, Gakuto Yozu, Masaya Shimojima, Chikaaki Motoda, Nozomi Hayashiji, Yuki Saito, Yu-Ichi Goto, Keiichi Fukuda

FEBS open bio 5 219-25, 2015

Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction. 

Kazuaki Nakajima, Jun Fujita, Makoto Matsui, Shugo Tohyama, Noriko Tamura, Hideaki Kanazawa, Tomohisa Seki, Yoshikazu Kishino, Akinori Hirano, Marina Okada, Ryota Tabei, Motoaki Sano, Shinya Goto, Yasuhiko Tabata, Keiichi Fukuda

PloS one 10(7) e0133308, 2015

The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter Registry. 

Jun Fujita, Shun Kohsaka, Ikuko Ueda, Taku Inohara, Yuichiro Maekawa, Akio Kawamura, Hideaki Kanazawa, Kentaro Hayashida, Ryota Tabei, Shugo Tohyama, Tomohisa Seki, Masahiro Suzuki, Motoaki Sano, Keiichi Fukuda

PloS one 10(7) e0133568, 2015

A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes. 

Natsuko Hemmi, Shugo Tohyama, Kazuaki Nakajima, Hideaki Kanazawa, Tomoyuki Suzuki, Fumiyuki Hattori, Tomohisa Seki, Yoshikazu Kishino, Akinori Hirano, Marina Okada, Ryota Tabei, Rei Ohno, Chihana Fujita, Tomoko Haruna, Shinsuke Yuasa, Motoaki Sano, Jun Fujita, Keiichi Fukuda

Stem cells translational medicine 3(12) 1473-83, December 2014

MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. 

Naoto Muraoka, Hiroyuki Yamakawa, Kazutaka Miyamoto, Taketaro Sadahiro, Tomohiko Umei, Mari Isomi, Hanae Nakashima, Mizuha Akiyama, Rie Wada, Kohei Inagawa, Takahiko Nishiyama, Ruri Kaneda, Toru Fukuda, Shu Takeda, Shugo Tohyama, Hisayuki Hashimoto, Yoshifumi Kawamura, Naoki Goshima, Ryo Aeba, Hiroyuki Yamagishi, Keiichi Fukuda, Masaki Ieda

The EMBO journal 33(14) 1565-81, 17 July 2014

Time-lapse imaging of cell cycle dynamics during development in living cardiomyocyte. 

Hisayuki Hashimoto, Shinsuke Yuasa, Hidenori Tabata, Shugo Tohyama, Nozomi Hayashiji, Fumiyuki Hattori, Naoto Muraoka, Toru Egashira, Shinichiro Okata, Kojiro Yae, Tomohisa Seki, Takahiko Nishiyama, Kazunori Nakajima, Asako Sakaue-Sawano, Atsushi Miyawaki, Keiichi Fukuda

Journal of molecular and cellular cardiology 72 241-9 , July 2014

Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2. 

Yoshinori Katsumata, Ken Shinmura, Yuki Sugiura, Shugo Tohyama, Tomohiro Matsuhashi, Hideyuki Ito, Xiaoxiang Yan, Kentaro Ito, Shinsuke Yuasa, Masaki Ieda, Yoshihiro Urade, Makoto Suematsu, Keiichi Fukuda, Motoaki Sano

Hypertension (Dallas, Tex. : 1979) 63(1) 80-7, January 2014

Generation and characterization of functional cardiomyocytes derived from human T cell-derived induced pluripotent stem cells. 

Tomohisa Seki, Shinsuke Yuasa, Dai Kusumoto, Akira Kunitomi, Yuki Saito, Shugo Tohyama, Kojiro Yae, Yoshikazu Kishino, Marina Okada, Hisayuki Hashimoto, Makoto Takei, Toru Egashira, Masaki Kodaira, Yusuke Kuroda, Atsushi Tanaka, Shinichiro Okata, Tomoyuki Suzuki, Mitsushige Murata, Jun Fujita, Keiichi Fukuda

PloS one 9(1) e85645, 2014

Derivation of transgene-free human induced pluripotent stem cells from human peripheral T cells in defined culture conditions. 

Yoshikazu Kishino, Tomohisa Seki, Jun Fujita, Shinsuke Yuasa, Shugo Tohyama, Akira Kunitomi, Ryota Tabei, Kazuaki Nakajima, Marina Okada, Akinori Hirano, Hideaki Kanazawa, Keiichi Fukuda

PloS one 9(5) e97397, 2014

Induction of human cardiomyocyte-like cells from fibroblasts by defined factors. 

Rie Wada, Naoto Muraoka, Kohei Inagawa, Hiroyuki Yamakawa, Kazutaka Miyamoto, Taketaro Sadahiro, Tomohiko Umei, Ruri Kaneda, Tomoyuki Suzuki, Kaichiro Kamiya, Shugo Tohyama, Shinsuke Yuasa, Kiyokazu Kokaji, Ryo Aeba, Ryohei Yozu, Hiroyuki Yamagishi, Toshio Kitamura, Keiichi Fukuda, Masaki Ieda

Proceedings of the National Academy of Sciences of the United States of America 110(31) 12667-72, 30 July 2013

Distinct iPS Cells Show Different Cardiac Differentiation Efficiency 

Yohei Ohno, Shinsuke Yuasa, Toru Egashira, Tomohisa Seki, Hisayuki Hashimoto, Shugo Tohyama, Yuki Saito, Akira Kunitomi, Kenichiro Shimoji, Takeshi Onizuka, Toshimi Kageyama, Kojiro Yae, Tomofumi Tanaka, Ruri Kaneda, Fumiyuki Hattori, Mitsushige Murata, Kensuke Kimura, Keiichi Fukuda

STEM CELLS INTERNATIONAL 2013 659739, 2013

Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes. 

Shugo Tohyama, Fumiyuki Hattori, Motoaki Sano, Takako Hishiki, Yoshiko Nagahata, Tomomi Matsuura, Hisayuki Hashimoto, Tomoyuki Suzuki, Hiromi Yamashita, Yusuke Satoh, Toru Egashira, Tomohisa Seki, Naoto Muraoka, Hiroyuki Yamakawa, Yasuyuki Ohgino, Tomofumi Tanaka, Masatoshi Yoichi, Shinsuke Yuasa, Mitsushige Murata, Makoto Suematsu, Keiichi Fukuda

Cell Stem Cell 12(1) 127-37, 03 January 2013

Distinct iPS Cells Show Different Cardiac Differentiation Efficiency. 

Yohei Ohno, Shinsuke Yuasa, Toru Egashira, Tomohisa Seki, Hisayuki Hashimoto, Shugo Tohyama, Yuki Saito, Akira Kunitomi, Kenichiro Shimoji, Takeshi Onizuka, Toshimi Kageyama, Kojiro Yae, Tomofumi Tanaka, Ruri Kaneda, Fumiyuki Hattori, Mitsushige Murata, Kensuke Kimura, Keiichi Fukuda

Stem cells international 2013 659739-659739, 2013

Myocardial cell sheet therapy and cardiac function.

Jun Fujita, Yuji Itabashi, Tomohisa Seki, Shugo Tohyama, Yuichi Tamura, Motoaki Sano, Keiichi Fukuda

American journal of physiology. Heart and circulatory physiology 303(10) H1169-82-1182, 15 November 2012

miR-142-3p is essential for hematopoiesis and affects cardiac cell fate in zebrafish. 

Takahiko Nishiyama, Ruri Kaneda, Tomohiko Ono, Shugo Tohyama, Hisayuki Hashimoto, Jin Endo, Hikaru Tsuruta, Shinsuke Yuasa, Masaki Ieda, Shinji Makino, Keiichi Fukuda

Biochemical and biophysical research communications 425(4) 755-61, 07 September 2012

Disease characterization using LQTS-specific induced pluripotent stem cells. 

Toru Egashira, Shinsuke Yuasa, Tomoyuki Suzuki, Yoshiyasu Aizawa, Hiroyuki Yamakawa, Tomohiro Matsuhashi, Yohei Ohno, Shugo Tohyama, Shinichiro Okata, Tomohisa Seki, Yusuke Kuroda, Kojiro Yae, Hisayuki Hashimoto, Tomofumi Tanaka, Fumiyuki Hattori, Toshiaki Sato, Shunichiro Miyoshi, Seiji Takatsuki, Mitsushige Murata, Junko Kurokawa, Tetsushi Furukawa, Naomasa Makita, Takeshi Aiba, Wataru Shimizu, Minoru Horie, Kaichiro Kamiya, Itsuo Kodama, Satoshi Ogawa, Keiichi Fukuda

Cardiovascular research 95(4) 419-29, 01 September 2012

The Overexpression of S105N Mutant Rad Leads Intracellular Ca2+ Overload Via Up-Regulation of Cardiac Ryanodine Receptor Activity 

Yamakawa Hiroyuki, Murata Mitsushige, Suzuki Tomoyuki, Yada Hirotaka, Mizusawa Mika, Tohyama Shugo, Ohgino Yasuyuki, Yuasa Shinsuke, Makino Shinji, Sano Motoaki, Kamiya Kaichiro, Fukuda Keiichi

Journal of Arrhythmia 27 OP32_5, 2011

Simple autogeneic feeder cell preparation for pluripotent stem cells. 

Weizhen Li, Hiromi Yamashita, Fumiyuki Hattori, Hao Chen, Shugo Tohyama, Yusuke Satoh, Erika Sasaki, Shinsuke Yuasa, Shinji Makino, Motoaki Sano, Keiichi Fukuda

Stem cell research 6(1) 83-9 , January 2011

Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. 

Tomohisa Seki, Shinsuke Yuasa, Mayumi Oda, Toru Egashira, Kojiro Yae, Dai Kusumoto, Hikari Nakata, Shugo Tohyama, Hisayuki Hashimoto, Masaki Kodaira, Yohei Okada, Hiroyuki Seimiya, Noemi Fusaki, Mamoru Hasegawa, Keiichi Fukuda

Cell Stem Cell 7(1) 11-4 , 02 July 2010

Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery. 

Mitsushige Murata, Shugo Tohyama, Keiichi Fukuda

Pharmacology & therapeutics 126(2) 109-18, May 2010

Nongenetic method for purifying stem cell-derived cardiomyocytes. 

Fumiyuki Hattori, Hao Chen, Hiromi Yamashita, Shugo Tohyama, Yu-Suke Satoh, Shinsuke Yuasa, Weizhen Li, Hiroyuki Yamakawa, Tomofumi Tanaka, Takeshi Onitsuka, Kenichiro Shimoji, Yohei Ohno, Toru Egashira, Ruri Kaneda, Mitsushige Murata, Kyoko Hidaka, Takayuki Morisaki, Erika Sasaki, Takeshi Suzuki, Motoaki Sano, Shinji Makino, Shinzo Oikawa, Keiichi Fukuda

Nature methods 7(1) 61-6 , January 2010

In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes. 

Tomofumi Tanaka, Shugo Tohyama, Mitsushige Murata, Fumimasa Nomura, Tomoyuki Kaneko, Hao Chen, Fumiyuki Hattori, Toru Egashira, Tomohisa Seki, Yohei Ohno, Uichi Koshimizu, Shinsuke Yuasa, Satoshi Ogawa, Shinya Yamanaka, Kenji Yasuda, Keiichi Fukuda

Biochemical and biophysical research communications 385(4) 497-502, 07 August 2009

患者まで届いている再生医療 難治性重症心不全患者を対象とした同種iPS細胞由来心筋スフェロイド移植

岸野 喜一, 市原 有起, 遠山 周吾

再生医療 23(2) 78-83, May 2024

三次元新組織の開発とその応用

谷 英典, 遠山 周吾*

実験医学 42(5) 728-735, March 2024

成熟度の高いオルガノイドを試験管内でいかに作り上げるか? ブタ臓器特異的細胞外基質の特性と心臓由来コラーゲンの利用

谷 英典, 遠山 周吾, 小林 英司

Organ Biology 31(1) 012-016, 2024

【心不全の最新治療-再生医療を用いた最新の知見】培養液を利用したヒトiPS細胞由来心筋細胞の大量選別法と品質評価法の開発

梅井 智彦, 森田 唯加, 遠山 周吾

カレントテラピー 42(1) 20-25, January 2024

多能性幹細胞における代謝機構に基づく心筋再生治療法の開発

遠山 周吾*

日本心不全学会 eLetter 2022年夏号, June 2022

ヒト多能性幹細胞の増殖促進法

亀田 康太郎, 染谷 将太, 遠山 周吾*

実験医学 39(16) 2605-2610, October 2021

細胞代謝機構に基づく選別を活用した臨床応用戦略

田野崎 翔, 遠山 周吾*

細胞 53(11) 9-12, September 2021

心臓再生医療に向けた基礎研究と臨床応用

亀田 康太郎, 遠山 周吾*

心臓 53(7) 671-676, July 2021

細胞内代謝機構に基づくヒトiPS細胞由来心筋作製と心臓再生医療への応用

遠山 周吾*

心臓 52(2) 227-232, February 2020

心筋再生医療の現状と今後の展望

関根 乙矢, 遠山 周吾*, 福田 恵一

循環器内科 87(4) 432-438, 2020

【U40世代が描く心不全診療の現状と未来-基礎研究を識り,臨床を素心深考する】基礎研究から知る臨床の未来 心筋再生はどこまで進んでいるの?

谷 英典, 遠山 周吾

循環器ジャーナル 68(1) 165-169, January 2020

【再生医療up to date】【多次元構造臓器の再生】ヒトiPS細胞由来微小心筋組織球の大量製造法の開発

遠山 周吾, 福田 恵一

腎と透析 86(3) 285-290, March 2019

【心不全のサイエンス 治療法開発をめざして心臓の謎を解く】(第2章)心疾患・心不全の分子病態の最先端 発生および分化における代謝シフトと可塑性

森田 唯加, 遠山 周吾

実験医学 37(5) 712-718, March 2019

ヒトiPS細胞を用いた心臓再生医療の現状と今後の展望

遠山 周吾, 田野崎 翔, 福田 恵一

日本臨床 76 38‐44, 31 December 2018

2次元培養系によるヒトiPS細胞由来心筋細胞の大量作製

遠山 周吾, 福田 恵一

Bio Industry 35(8) 14‐21, 12 August 2018

臨床応用前夜となったヒトiPS細胞を用いた心臓再生医療

福田 恵一, 遠山 周吾, 関 倫久, 中嶋 一晶, 湯浅 慎介, 金澤 英明, 藤田 淳

医工学治療 30(Suppl.) 47-47, 01 March 2018

創薬シリーズ 創薬研究の新潮流 分化心筋細胞を用いた重症心不全における再生医療研究

田野崎 翔, 遠山 周吾, 福田 恵一

日本薬理学雑誌 150(5) 246-250, November 2017

再生医療・遺伝子治療 ヒトiPS細胞を用いた心臓再生医療実現化における現状と課題

遠山 周吾, 福田 恵一

Cardiac Practice 28(3) 181‐185, 30 July 2017

ヒト多能性幹細胞および分化心筋細胞における代謝環境への適応能

遠山 周吾, 福田 恵一

適応医学 20(2) 8‐14, 10 July 2017

【再生医療・遺伝子治療】 基礎 ヒトiPS細胞を用いた心臓再生医療実現化における現状と課題

遠山 周吾, 福田 恵一

Cardiac Practice 28(3) 181-185, July 2017

ヒト多能性幹細胞および分化心筋細胞における代謝環境への適応能

遠山 周吾, 福田 恵一

適応医学 20(2) 8-14, July 2017

心筋再生医療 前臨床研究から臨床応用へ向けた課題とその克服

福田 恵一, 遠山 周吾, 國富 晃, 湯浅 慎介, 中嶋 一晶, 関 倫彦, 藤田 淳

糖尿病 60(Suppl.1) S-5, April 2017

代謝を利用したヒトiPS細胞由来心筋細胞におけるふるい分け技術の確立

遠山 周吾, 藤田 淳, 菱木 貴子, 末松 誠, 福田 恵一

再生医療 16, 2017

ヒト多能性幹細胞におけるグルタミン代謝の役割と再生医療への応用 

遠山 周吾, 福田 恵一

月刊臨床免疫・アレルギー科 66(6) 627‐632-632, 25 December 2016

ヒト多能性幹細胞におけるグルタミン代謝の役割と再生医療への応用

遠山 周吾, 福田 恵一

臨床免疫・アレルギー科 66(6) 627-632, December 2016

20年後の再生医療を予測する 循環器領域へのiPS細胞の臨床応用の現状

福田 恵一, 遠山 周吾, 関 倫久, 湯浅 慎介, 藤田 淳

循環器専門医 24(2) 242-251, August 2016

iPS細胞を用いた循環器領域の再生医療

福田 恵一, 遠山 周吾, 関 倫久, 湯浅 慎介, 下地 顕一郎, 藤田 淳

日本内科学会雑誌 105(7) 1287‐1295, 10 July 2016

ヒト多能性幹細胞におけるグルタミン代謝を利用した心臓再生医療

遠山 周吾, 藤田 淳, 菱木 貴子, 末松 誠, 福田 恵一

日本分子生物学会年会プログラム・要旨集(Web) 39th, 2016

心筋再生の現状と展望 ヒトiPS細胞由来分化細胞における未分化幹細胞除去と心筋純化精製

遠山 周吾

最新医学 70(8) 1618-1624, 10 August 2015

【心筋再生の現状と展望】 ヒトiPS細胞由来分化細胞における未分化幹細胞除去と心筋純化精製

遠山 周吾

最新医学 70(8) 1618-1624, August 2015

【再生医療2015 幹細胞と疾患iPS細胞の研究最前線】 (第3章)疾患iPS細胞 疾患特異的ヒトiPS細胞由来心筋細胞を用いた遺伝性循環器疾患解析

遠山 周吾, 福田 恵一

実験医学 33(2) 292-298, February 2015

疾患iPS細胞 3.疾患特異的ヒトiPS細胞由来心筋細胞を用いた遺伝性循環器疾患解析

遠山 周吾, 福田 恵一

実験医学 33(2) 292-298, 01 February 2015

代謝的アプローチによるヒトES/iPS細胞を用いた心臓再生医療

遠山 周吾, 藤田 淳, 服部 文幸, 菱木 貴子, 末松 誠, 福田 恵一

再生医療 14, 2015

代謝制御を基盤とした心臓再生医療

遠山 周吾, 藤田 淳, 服部 文幸, 菱木 貴子, 末松 誠, 福田 恵一

日本血管生物医学会学術集会プログラム・抄録集 23rd, 2015

心臓再生医療で乗り越えなければならないハードルとは―心臓再生医療における現状と課題

遠山 周吾, 福田 恵一

循環器内科 76(5) 500-505, 28 November 2014

心臓再生医療で乗り越えなければならないハードルとは-心臓再生医療における現状と課題

遠山 周吾, 福田 恵一

循環器内科 76(5) 500-505, November 2014

ゼラチンハイドロゲルを使用した,不全心に対する心筋細胞移植による急性期機能改善と移植効率の検討

中嶋 一晶, 藤田 淳, 松井 誠, 遠山 周吾, 金澤 英明, 関 倫久, 岸野 喜一, 平野 暁教, 岡田 麻里奈, 邉見 奈津子, 田部井 亮太, 大野 麗, 佐野 元昭, 田畑 泰彦, 福田 恵一

日本心臓病学会学術集会抄録(CD-ROM) 62nd ROMBUNNO.P-537-537, 02 September 2014

代謝的アプローチによるESおよびiPS細胞における未分化幹細胞除去法および心筋精製法

遠山 周吾, 福田 恵一

Cytometry Research 24(1) 1-6, 25 April 2014

発生学・再生学シリーズ 網羅的代謝解析の再生医学への応用

遠山 周吾

血管医学 14(4) 435-441, 20 February 2014

心臓移植治療の現在

遠山 周吾, 香坂 俊

Medicina 51(2) 370-376, 10 February 2014

【循環器再生医療の現状と展望】 メタボローム解析を利用したES・iPS由来心筋細胞における純化精製法の確立 

遠山 周吾, 福田 恵一

Circulation 3(9) 47-53, September 2013

【細胞移植】 ヒトESおよびiPS細胞を用いた心臓再生医療の課題と展望

遠山 周吾, 福田 恵一

細胞 45(7) 319-322, July 2013

心不全の基礎と臨床 重症心不全における心臓再生医療

遠山 周吾, 福田 恵一

月刊メディカル・サイエンス・ダイジェスト 39(7) 314-317, 30 June 2013

iPS細胞の純化・安全性 ES細胞およびiPS細胞における未分化幹細胞除去法および心筋精製法 

遠山 周吾, 服部 文幸, 福田 恵一

Cytometry Research 23(Suppl.) 50-50, June 2013

iPS細胞の現状と近未来 メタボローム解析を用いたヒトES/iPS由来心筋細胞における純化精製法の確立 

遠山 周吾

日本DDS学会学術集会プログラム予稿集 29回 66-66, 01 June 2013

慢性呼吸器疾患:ベッドサイドの運動負荷試験―実践と理論 基礎医学とのダイアローグ ESおよびiPS細胞由来心筋細胞における代謝の特性を利用した大量精製法 

遠山 周吾, 福田 恵一

THE LUNG-perspectives 21(2) 179-182, 01 May 2013

ES/iPS細胞由来心筋細胞における代謝的精製法の構築

遠山 周吾

心臓 44(12) 1636-1636, December 2012

幹細胞の臨床応用 ES/iPS由来心筋細胞を用いた心臓再生医療 

遠山 周吾, 福田 恵一

月刊メディカル・サイエンス・ダイジェスト 38(11) 483-485, 25 October 2012

ヒトiPS由来心筋の電気生理学的性質におよぼす分化誘導時間の影響

黒川 洵子, 遠山 周吾, 村田 光繁, 古川 哲史, 福田 恵一

日本薬学会年会要旨集 132年会(3) 175-175, March 2012

代謝の特性を利用したヒトES/iPS由来心筋細胞精製法

遠山 周吾, 服部 文幸, 佐野 元昭, 福田 恵一

血管 35(1) 19, 31 January 2012

再生医療研究の最先端 代謝の特性を利用したヒトES/iPS由来心筋細胞精製法

遠山 周吾, 服部 文幸, 佐野 元昭, 福田 恵一

血管 35(1) 19-19, January 2012

iPS細胞の電気生理学 心電学への応用とその将来展望 ヒトiPS細胞由来心筋細胞の電気生理学 パッチクランプ実験 

古川 哲史, 黒川 洵子, 大方 信一郎, 遠山 周吾, 湯浅 慎介, 村田 光繁, 福田 恵一

心電図 31(3) 325-328, August 2011

ヒトiPS由来心筋細胞の電気生理学的特性について 

遠山 周吾, 村田 光繁, 黒川 洵子, Fernando Lopez-Redondo, 服部 文幸, 水澤 美香, 山川 裕之, 橋本 寿之, 江頭 徹, 関 朋久, 扇野 泰行, 八戸 宏二郎, 湯浅 慎介, 福田 恵一

心電図 30(Suppl.4) S-4, September 2010

iPS細胞の創薬研究への利用 循環器疾患とiPS細胞 

遠山 周吾, 福田 恵一

月刊メディカル・サイエンス・ダイジェスト 35(12) 497-500, 31 October 2009

「移植医療におけるiPS細胞研究のインパクト」ES細胞・iPS細胞からの心筋細胞分化・精製・移植 

遠山 周吾, 服部 文幸, 福田 恵一

移植 44(3) 219-225, 10 June 2009